Aurobindo Pharma has reported results for second quarter ended September 30, 2024 (Q2FY25). 

The company has reported 29.29% rise in its net profit at Rs 537.53 crore for the quarter ended September 30, 2024 as compared to Rs 415.74 crore for the same quarter in the previous year. Total income of the company increased by 7.73% at Rs 2,947.25 crore for Q2FY25 as compared to Rs 2,735.84 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 8.65% rise in net profit at Rs 816.95 crore for Q2FY25 as compared to Rs 751.94 crore for the same quarter in the previous year. Total income of the company increased by 7.10% at Rs 7,932.07 crore for Q2FY25 as compared to Rs 7,406.40 crore for the corresponding quarter previous year.